Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined Therapy in ERAS for Accelerated Orthopedic Rehabilitation
NCT07273032Phase 4
Key facts
- Status
- Not yet recruiting
- Start
- Dec 2025
- Primary completion
- Dec 2025
- Sponsor
- Ningbo Medical Centre Lihuili Hospital
- Modality
- Small Molecules
- Conditions
- meniscus injury
01
Overview
Phase 4, randomised, double-blind trial of Heng-Gu-Gu-Shang-Yu-He-Ji in meniscus injury (4 arms), sponsored by Ningbo Medical Centre Lihuili Hospital. Primary endpoints: Visual Analog Scale at 6 months, Limb Symmetry Index at 6 months and 4 more. Planned start Dec 2025; status: not yet recruiting.
02
Design
4 arms- Study design
- RandomizedDouble-blind
Blank control group
Underwent meniscus plasty under knee arthroscopy, no additional intervention
Henggu Bone Injury Healing Agent Intervention Group
Henggu Bone Injury Healing Agent for 6 weeks post-operation
Lower limb rehabilitation training system intervention group
Systematic intervention of lower limb rehabilitation training post-operation
Combined intervention group
Henggu Bone Injury Healing Agent + lower limb rehabilitation training system post-operation
03
Who it enrols
Patients aged 20-65 with meniscus injury undergoing arthroscopic repair, excluding those with severe obesity, cognitive dysfunction, or severe heart/liver/kidney insufficiency.
04
Endpoints
Primary
Visual Analog Scale
Limb Symmetry Index
Hospital for Special Surgery Knee Score
Lysholm Knee Scoring Scale
International Knee Documentation Committee Knee Score
Beyond the preview
Go deeper on NCT07273032.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07273032.